Clinical Trial

Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease

Study acronym: GENOSS PCB
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The GENOSS PCB study aims to evaluate the safety and efficacy of a Paclitaxel-coated PTA Balloon Catheter(GENOSS® PCB) in patients with the femoropopliteal artery disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-02; most recent amendment 2026-02-13.
Trial Details
NCT Number NCT07399080
Lead Sponsor Genoss Co., Ltd.
Conditions PTA (Percutaneous Transluminal Angioplasty ), Femoropopliteal Artery Disease
Enrollment 200 participants
Start Date 2025-07-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-18